Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Somatostatin may help protect hair follicles from immune attacks.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

miR-486 may help prevent hair loss in alopecia areata.

Blue light can help hair grow by affecting certain receptors in hair follicles.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Ginseng and Albizia extracts may help prevent age-related hair thinning.

Biotrinine® may be an effective treatment for chronic hair loss.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.